Vija Riekstina - Publications

Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort study.

Journal: The Lancet regional health. Europe

Published: December 04, 2025

Adverse drug reactions, particularly liver disorders, drive interruptions in anti-tuberculosis treatment: A retrospective cohort study.

Journal: British journal of clinical pharmacology

Published: May 01, 2025

Endogenous reactivation cases identified by whole genome sequencing of Mycobacterium tuberculosis: Exploration of possible causes in Latvian tuberculosis patients.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: November 19, 2024

TB management in the European Union/European Economic Area: a multi-centre survey.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: March 03, 2021

Healthcare delivery for HIV-positive people with tuberculosis in Europe.

Journal: HIV medicine

Published: October 12, 2020

Analysis of Mycobacterium tuberculosis genetic lineages circulating in Riga and Riga region, Latvia, isolated between 2008 and 2012.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: July 17, 2019

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Journal: Lancet (London, England)

Published: February 24, 2018

"Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.

Journal: PloS one

Published: January 24, 2018

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

Journal: The European respiratory journal

Published: December 22, 2017

Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?

Journal: Thorax

Published: December 09, 2016

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.

Journal: Emerging infectious diseases

Published: February 19, 2016

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 04, 2015